Treatment Strategy for Fatal Arrhythmias in Ebstein's Anomaly Combined With Leadless Pacemaker And S-ICD Implantations

Overview

Journal JACC Case Rep

Specialty Cardiology & Vascular Diseases

Date 2022 Dec 12

PMID 36507289

Authors

Mitsuru Takami

Koji Fukuzawa

Kunihiko Kiuchi

Kensuke Matsumoto

Yu Izawa

Ken-Ichi Hirata

Affiliations

Soon will be listed here.

Abstract

The management of heart rhythm disorders in patients with adult congenital heart disease and limited vascular access is challenging. We present the case of a 38-year-old woman with Ebstein's anomaly who underwent implantation of a combination of a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator to manage fatal arrhythmias. ().

Citing Articles

A dual-chamber leadless pacemaker implantation across percutaneous tricuspid valve-in-valve prosthesis in a patient with Ebstein anomaly.

Al-Ghamdi B, Salem M, Echahidi M HeartRhythm Case Rep. 2025; 11(2):104-107.

PMID: 40018306 PMC: 11861930. DOI: 10.1016/j.hrcr.2024.10.016.

Device Therapy in Cardiac Sarcoidosis: Current Review, Challenges, and Future Prospects.

ElRefai M, Menexi C, Roberts P J Innov Card Rhythm Manag. 2024; 15(11):6088-6094.

PMID: 39563989 PMC: 11573303. DOI: 10.19102/icrm.2024.15115.

Combining Leadless Pacemaker With a Subcutaneous Implantable Cardioverter-Defibrillator: With Self-Discipline Most Anything Is Possible.

Ramandi M, Santangeli P JACC Case Rep. 2022; 4(23):101639.

PMID: 36507925 PMC: 9730149. DOI: 10.1016/j.jaccas.2022.09.009.

References

Elliott M, Sidhu B, Mehta V, Gould J, Martic D, Rinaldi C . The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems. HeartRhythm Case Rep. 2021; 7(9):628-632. PMC: 8441212. DOI: 10.1016/j.hrcr.2021.06.006. View

Akin I, Roger S, Borggrefe M, Kuschyk J . Impeding Sudden Cardiac Death Despite Subcutaneous Implantable Defibrillator Due to Fatal Crosstalk. J Cardiovasc Electrophysiol. 2015; 27(5):613-4. DOI: 10.1111/jce.12871. View

Zormpas C, Silber-Peest A, Eiringhaus J, Hillmann H, Hohmann S, Muller-Leisse J . Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease. ESC Heart Fail. 2021; 8(2):1502-1508. PMC: 8006645. DOI: 10.1002/ehf2.13243. View

Ng J, Chua K, Teo W . Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-When vascular options have run out. J Arrhythm. 2019; 35(1):136-138. PMC: 6373655. DOI: 10.1002/joa3.12140. View

Ito R, Kondo Y, Winter J, Hayashi T, Nakano M, Kajiyama T . Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis. J Arrhythm. 2019; 35(2):311-313. PMC: 6457394. DOI: 10.1002/joa3.12152. View